NEW YORK, Oct 24 – Orchid BioSciences has purchased an option to co-develop and co-commercialize DNAPrint genomics’ SNP-disease associations and other intellectual properties, the companies said Tuesday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.